Harrison provided great insight into the industry and helped us get our business off the ground. He helped us organize and prepare our application and continues to help us whenever we reach out with questions. He always replies promptly and is very knowledgeable. We would highly recommend Harrison!
Psychedelics Lawyer Canada
Substance Law provides legal and regulatory services to organizations and individuals operating in Canada’s highly regulated psychedelics and controlled substances sector.
Takes about 60 seconds · No commitment
Tell us what you need
By submitting this form, you agree to Substance Law Privacy Policy and Terms of Use.
Canada's Law Firm For Regulated Substances
Law Firm for Psilocybin (Magic Mushrooms), MDMA, LSD and other Hallucinogens
Substance Law provides legal and regulatory services to organizations and individuals operating in Canada’s highly regulated psychedelics and controlled substances sector. We advise clients on licensing, compliance, audits, enforcement, transactions, and regulatory strategy involving substances regulated under the Controlled Drugs and Substances Act (CDSA) and overseen by Health Canada.
Psychedelic substances such as psilocybin, MDMA, LSD, DMT, mescaline, and other controlled substances are subject to strict federal controls. Navigating this legal framework requires careful planning, regulator-aware strategy, and ongoing compliance support.
Psychedelics Legal Services
CDSA Dealer’s Licences & Authorizations
We assist clients with regulatory pathways to lawfully engage in activities involving psychedelics, including:
- Dealer’s Licence applications
- Licence amendments and scope changes
- Regulatory strategy for research, manufacturing, and commercialization
- Responding to Health Canada questions and deficiencies
Licensing is often the cornerstone of lawful psychedelic operations in Canada.
Research, Clinical Trials & Medical Access
We advise clients involved in psychedelic research and therapeutic development, including:
- Regulatory strategy for research activities
- Interactions with Health Canada related to trials and studies
- Compliance obligations for controlled substances
- Risk management for investigators and sponsors
We support both early-stage research and more advanced clinical or therapeutic programs.
Compliance Programs & Operational Readiness
Licensed or authorized activities come with strict operational obligations. We assist with:
- Security and site compliance planning
- Record-keeping and inventory controls
- Standard operating procedures (SOPs)
- Internal compliance programs and audits
Ongoing compliance is critical to maintaining authorization and avoiding enforcement action.
Inspections, Audits & Enforcement Matters
We represent clients in connection with:
- Health Canada inspections and audits
- Warning letters and notices of non-compliance
- Licence suspensions, refusals, or revocations
- Enforcement risk assessment and remediation
Early legal involvement can significantly affect regulatory outcomes.
Import, Export & International Operations
We advise on:
- Import and export permits for controlled substances
- Cross-border regulatory requirements
- Coordination with international partners and regulators
- Ongoing reporting and compliance obligations
International movement of psychedelics is closely scrutinized and must be carefully managed.
Transactions, Investment & Commercial Agreements
We support psychedelic businesses with:
- Regulatory due diligence for investments and acquisitions
- Structuring transactions involving licensed activities
- Drafting, reviewing, and negotiating commercial agreements
- Risk allocation in research, manufacturing, and supply contracts
Regulatory status and compliance posture are often central to deal viability.
Who We Assist
We advise a wide range of clients in the psychedelics space, including:
- Researchers and research institutions
- Biotech and pharmaceutical companies
- Manufacturers and laboratories
- Clinical trial sponsors
- Importers and exporters
- Investors and strategic partners
Why Choose Substance Law as Your Psychedelics Lawyer?
- Experience with CDSA and Health Canada frameworks
- Practical understanding of licensing and compliance risk
- Strategic, business-focused legal advice
- Support from early research through commercialization
- Toronto-based firm serving clients across Canada
Work With a Psychedelics Lawyer in Canada
If you are researching, producing, importing, exporting, or commercializing psychedelic substances in Canada, Substance Law provides experienced legal guidance tailored to CDSA-regulated activities.
Contact us today to speak with a Psychedelics Lawyer in Canada.
Psychedelics Licences (CDSA Dealer’s Licence)
Get a Licence to Produce, Sell, Import and Export MDMA, Psilocybin, LSD and Other Psychedelics in Canada
Substance Law provides legal and regulatory services to organizations seeking authorization to produce, possess, sell, distribute, import, or export controlled psychedelics in Canada under the Controlled Drugs and Substances Act (CDSA).
We assist clients with Dealer’s Licence applications, regulatory strategy, compliance program development, audits, and ongoing obligations overseen by Health Canada.
Psychedelic substances such as MDMA, psilocybin, LSD, DMT, mescaline, and other controlled substances are highly regulated in Canada. Operating without proper authorization carries significant criminal, regulatory, and reputational risk. Our role is to help clients navigate this framework lawfully and strategically.
Psychedelics & CDSA Licensing in Canada
Under the CDSA and its regulations, activities involving controlled substances are generally prohibited unless expressly authorized by Health Canada. A Dealer’s Licence is the primary authorization used by:
- Researchers
- Manufacturers
- Clinical trial sponsors
- Pharmaceutical and biotech companies
- Contract manufacturers and laboratories
- Exporters and importers of controlled substances
CDSA Dealer’s Licence Services
Dealer’s Licence Applications
We assist with preparing and submitting Dealer’s Licence applications for activities involving psychedelics, including:
- Production and synthesis
- Possession and storage
- Sale and distribution (where permitted)
- Import and export
- Research and analytical testing
We guide clients through each stage of the application process, including responding to Health Canada questions and deficiencies.
Substances Commonly Addressed
We regularly advise on licensing matters involving substances such as:
- Psilocybin and psilocin
- MDMA
- LSD
- DMT
- Mescaline
- Other Schedule I and Schedule III substances
The applicable regulatory pathway depends on the substance, activity, and end use.
Regulatory Strategy & Scope Assessment
We help clients determine:
- Whether a Dealer’s Licence or another authorization is required
- The appropriate licence category and scope
- How proposed activities align with CDSA requirements
- Risks associated with research, manufacturing, or commercialization plans
Early regulatory strategy is critical to avoiding delays or refusals.
Security, Record-Keeping & Compliance Programs
Dealer’s Licence holders are subject to strict operational requirements. We assist with:
- Physical security and site compliance planning
- personnel security clearance strategy
- Record-keeping systems and SOPs
- Inventory controls and reporting obligations
- Internal compliance programs and audits
Non-compliance can result in licence suspension, revocation, or enforcement action.
Inspections, Audits & Enforcement Matters
We assist clients with:
- Preparing for Health Canada inspections
- Responding to inspection findings
- Managing compliance communications
- Addressing potential enforcement risks
Proactive legal involvement can significantly reduce operational disruption.
Import & Export of Psychedelics
We advise on:
- Import and export permits for controlled substances
- Cross-border regulatory requirements
- Coordination with foreign regulators and partners
- Ongoing reporting and compliance obligations
International movement of psychedelics is heavily scrutinized and must be carefully managed.
Transactions, Research & Commercialization Support
We also advise clients on:
- Regulatory due diligence for investments and acquisitions
- Structuring research and development arrangements
- Contract drafting, review, and negotiation
- Risk allocation in commercial and research agreements
Licensing status and compliance posture are often central to transactions in this space.
Why Choose Substance Law for Psychedelics Licensing?
- Experience with CDSA and Health Canada regulatory frameworks
- Practical understanding of Dealer’s Licence requirements
- Strategic, compliance-focused legal advice
- Support from application through ongoing operations
- Toronto-based firm serving clients across Canada
Work With a Psychedelics Licence Lawyer in Canada
If you are seeking authorization to produce, possess, sell, import, or export psychedelics in Canada, Substance Law provides experienced legal guidance tailored to CDSA-regulated activities.
Contact us today to speak with a Psychedelics Licence Lawyer in Canada.
Frequently Asked Questions About Psychedelics Lawyers in Canada
Many psychedelics (including psilocybin, MDMA, LSD, DMT, and mescaline) are controlled substances in Canada. Activities involving controlled substances are generally prohibited unless specifically authorized by Health Canada under the Controlled Drugs and Substances Act (CDSA) and related regulations.
A psychedelics lawyer helps clients navigate Canadian controlled substances law, including licensing strategy, compliance program development, import/export permitting, audit and inspection readiness, enforcement response, and legal support for transactions and contracts in regulated operations.
a CDSA Dealer’s Licence is a Health Canada authorization that may allow certain activities with controlled substances such as production, possession, sale, distribution, import/export, and research or analytical testing—subject to strict conditions. Whether you need a Dealer’s Licence depends on your activities and business model.
Yes. We help clients prepare for inspections and audits, respond to Health Canada correspondence (including warning letters and compliance notices), address findings, and implement remediation strategies to reduce enforcement risk.
Yes. We advise on permit strategy and compliance for import and export of controlled substances, including regulatory requirements, documentation, and communications with Health Canada related to cross-border activity.
Yes. We assist clients with operational compliance frameworks, including security planning, inventory controls, record-keeping systems, SOPs, internal audits, and governance processes aligned with licensing and regulatory requirements.
Yes. We provide contract drafting, review, and negotiation as well as regulatory due diligence and transaction support for investments, acquisitions, manufacturing arrangements, supply agreements, and research collaborations involving regulated activities.
Yes. We advise a range of clients, including researchers, clinical trial sponsors, labs, manufacturers, importers/exporters, and businesses involved in regulated psychedelic activities.
Timelines vary based on application complexity, site readiness, security requirements, and Health Canada review. Applications may take several months and can involve follow-up questions or requests for additional information.
Costs depend on the scope of work—such as licensing applications, compliance program development, audits/inspections, import/export permitting, or transactions. Many matters can be handled on an hourly or scoped fixed-fee basis after an initial review.
Psychedelics such as psilocybin, MDMA, LSD, DMT, and mescaline are controlled substances in Canada. Activities involving these substances are generally illegal unless specifically authorized by Health Canada under the Controlled Drugs and Substances Act (CDSA).
A CDSA Dealer’s Licence is an authorization issued by Health Canada that permits licensed entities to conduct specified activities with controlled substances, such as producing, possessing, selling, importing, exporting, or conducting research, subject to strict conditions.
A Dealer’s Licence may be required by researchers, manufacturers, laboratories, pharmaceutical or biotech companies, clinical trial sponsors, and others seeking to lawfully handle psychedelics for research, analytical, medical, or commercial purposes.
Dealer’s Licences may cover substances such as psilocybin, psilocin, MDMA, LSD, DMT, mescaline, and other Schedule I or Schedule III substances, depending on the scope of the licence and Health Canada approval.
Permitted activities may include production, synthesis, possession, storage, sale, distribution, import, export, research, and analytical testing. The specific activities allowed depend on the licence terms and regulatory approval.
Timelines vary depending on the complexity of the application, security requirements, site readiness, and Health Canada review. Applications often take several months and may involve requests for additional information.
Licence holders must meet strict requirements relating to physical security, personnel security clearances, record-keeping, inventory controls, reporting, and inspections. Ongoing compliance is essential to maintaining the licence.
Yes. Health Canada may conduct inspections to verify compliance with licence conditions and regulatory requirements. Inspections may occur before licensing and on an ongoing basis after a licence is granted.
Yes, but import and export activities typically require additional permits and must comply with both Canadian and international regulatory requirements. Each shipment is usually subject to approval.
Yes. A lawyer can assist with licence strategy, application preparation, responding to Health Canada questions, compliance program design, inspections, audits, enforcement issues, and related contracts or transactions.
Quoted In The Following Reputable Media
Testimonials
Built On Trust & Precision.
Don't just take our word for it. Here is what our clients have to say about our service.
200+ client reviews
Contact
Get Strategic Counsel. Now.
You want to move fast, and you're looking for a law firm equipped to handle your challenges. That's where we fit in.
- Book a Consultation Schedule a time that works for you.
- Flexible Options Transparent pricing and fixed-fee options available.
- Quick Response Typically within one business day.
- Confidential Your information is always private.
Takes about 60 seconds · No commitment
Tell us what you need
By submitting this form, you agree to Substance Law Privacy Policy and Terms of Use.
Canada's Law Firm For Regulated Substances
